Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear

BMC Neuroscience

Volumn 11, Issue , 2010, Pages

  Hori, Ryusuke ^a   Nakagawa, Takayuki ^a   Yamamoto, Norio ^a   Hamaguchi, Kiyomi ^a   Ito, Juichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; FLT1 PROTEIN, MOUSE; MESSENGER RNA; PROSTAGLANDIN E2 RECEPTOR, EP4 SUBTYPE; PROSTAGLANDIN EP2 RECEPTOR; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; COCHLEA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INNER EAR; MALE; MOUSE; NEUROEPITHELIUM; NONHUMAN; PARACRINE SIGNALING; PERCEPTION DEAFNESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPIRAL GANGLION; SPIRAL LIGAMENT; STRIA VASCULARIS; ANIMAL; C57BL MOUSE; DRUG EFFECT; DRUG POTENTIATION; METABOLISM;

ANIMALS; COCHLEA; EAR, INNER; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, PROSTAGLANDIN E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPIRAL GANGLION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77949434556     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-11-35     Document Type: Article

References (39)

1. Wei BP, Mubiru S, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2006, 25:CD003998.
2. Ogawa K, Takei S, Inoue Y, Kanzaki J. Effect of prostaglandinE1 on idiopathic sudden sensorineural hearing loss: a doubleblinded clinical study. Otol Neurotol 2002, 23:665-668. 10.1097/00129492-200209000-00011, 12218617.
3. Ahn JH, Kim MR, Kim HC. Therapeutic effect of lipoprostaglandin E1 on sudden hearing loss. Am J Otolaryngol 2005, 26:245-248. 10.1016/j.amjoto.2005.01.009, 15991090.
4. Suzuki H, Fujimura T, Shiomori T, Ohbuchi T, Kitamura T, Hashida K, Udaka T. Prostaglandin E1 versus steroid in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2008, 35:192-197. 10.1016/j.anl.2007.06.003, 17826927.
5. Zhuo XL, Wang Y, Zhuo WL, Zhang XY. Is the application of prostaglandin E1 effective for the treatment of sudden hearing loss? An evidence-based meta-analysis. J Int Med Res 2008, 36:467-70.
6. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 1997, 122:217-224. 10.1038/sj.bjp.0701367, 1564924, 9313928.
7. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999, 79:1193-1226.
8. Coleman RA, Smith WL, Narumiya S. International union of pharmacology classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol Rev 1994, 46:205-229.
9. Hori R, Nakagawa T, Sugimoto Y, Sakamoto T, Yamamoto N, Hamaguchi K, Ito J. Prostaglandin E receptor subtype EP4 agonist protects auditory hair cells against noise-induced trauma. Neuroscience 2009, 160:813-819. 10.1016/j.neuroscience.2009.03.014, 19303430.
10. Inoue H, Takamori M, Shimoyama Y, Ishibashi H, Yamamoto S, Koshihara Y. Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts. Br J Pharmacol 2002, 136:287-295. 10.1038/sj.bjp.0704705, 1573344, 12010778.
11. Weiss TW, Mehrabi MR, Kaun C, Zorn G, Kastl SP, Speidl WS, Pfaffenberger S, Rega G, Glogar HD, Maurer G, Pacher R, Huber K, Wojta J. Prostaglandin E1 induces vascular endothelial growth factor-1 in human adult cardiac myocytes but not in human adult cardiac fibroblasts via a cAMP-dependent mechanism. Mol Cell Cardiol 2004, 36:539-546.
12. Bradbury D, Clarke D, Seedhouse C, Corbett L, Stocks J, Knox A. Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites. J Biol Chem 2005, 28:29993-30000.
13. Jain S, Chakraborty G, Raja R, Kale S, Kundu GC. Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res 2008, 68:7750-7759. 10.1158/0008-5472.CAN-07-6689, 18829529.
14. Gerber HP, Dixit V, Ferrara N. Vascular endotheliul growth factor induces expression of the antiapoptotic proteins Bcl-2 and A 1 in vascular endothelial cells. J Biol Chem 1998, 273:13313-13316. 10.1074/jbc.273.21.13313, 9582377.
15. Cross MJ, Dixelius J, Matsumoto T, Claesson-Wslsh L. VEGF-receptor signal transduction. Trends Biochem Sci 2003, 28:488-494. 10.1016/S0968-0004(03)00193-2, 13678960.
16. Ferrara N, Gerber HP, LeCouter J. he biology of VEGF and its receptors. Nat Med 2003, 9:669-676. 10.1038/nm0603-669, 12778165.
17. Ding XM, Mao BY, Jiang S, Li SF, Deng YL. Neuroprotective effect of exogenous vascular endothelial growth factor on rat spinal cord neurons in vitro hypoxia. Chin Med J 2005, 118:1644-1650.
18. Góra-Kupilas K, Jośko J. The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol 2005, 43:31-39.
19. Zachary I. Neuroprotective role of vascular endothelial growth factor: signaling mechanisms, biological function, and therapeutic potential. Neurosignals 2005, 14:207-221. Review, 10.1159/000088637, 16301836.
20. Picciotti PM, Fetoni AR, Paludetti G, Wolf FI, Torsello A, Troiani D, Ferraresi A, Pola R, Sergi B. Vascular endothelial growth factor (VEGF) expression in noise-induced hearing loss. Hear Res 2006, 214:76-83. 10.1016/j.heares.2006.02.004, 16603326.
21. Selivanova O, Heinrich UR, Brieger J, Feltens R, Mann W. Fast alterations of vascular endothelial growth factor (VEGF) expression and that of its receptors (Flt-1, Flk-1 and Neuropilin) in the cochlea of guinea pigs after moderate noise exposure. Eur Arch Otorhinolaryngol 2007, 264:121-128. 10.1007/s00405-006-0154-3, 17031660.
22. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 2005, 90:7533-7537.
23. Wen Y, Edelman JL, Kang T, Zeng N, Sachs G. Two functional forms of vascular endothelial growth factor receptor-2/Flk-1 mRNA are expressed in normal rat retina. J Biol Chem 1998, 273:2090-2097. 10.1074/jbc.273.4.2090, 9442048.
24. Wang X, Klein RD. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway. Mol Carcinog 2007, 46:912-923. 10.1002/mc.20320, 17427962.
25. Sales KJ, Maudsley S, Jabbour HN. Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3', 5'-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathway. Mol Endocrinol 2005, 18:1533-1545.
26. Rosenstein JM, Krum JM. New roles for VEGF in nervous tissue--beyond blood vessels. Exp Neurol 2004, 187:246-253. 10.1016/j.expneurol.2004.01.022, 15144851.
27. Michel O, Hess A, Bloch W, Schmidt A, Stennert E, Addicks K. Immunohistochemical detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR/Flk-1 in the cochlea of guinea pigs. Hear Res 2001, 155:175-180. 10.1016/S0378-5955(01)00262-3, 11335087.
28. Picciotti P, Torsello A, Wolf FI, Paludetti G, Gaetani E, Pola R. Age-dependent modifications of expression level of VEGF and its receptors in the inner ear. Exp Gerontol 2004, 39:1253-1258. 10.1016/j.exger.2004.06.003, 15288700.
29. Picciotti PM, Torsello A, Cantore I, Stigliano E, Paludetti G, Wolf FI. Expression of vascular endothelial growth factor and its receptors in the cochlea of various experimental animals. Acta Otolaryngol 2005, 125:1152-1157. 10.1080/00016480510044241, 16353391.
30. Shi X. Cochlear pericyte responses to acoustic trauma and the involvement of hypoxia-inducible factor-1alpha and vascular endothelial growth factor. Am J Pathol 2009, 174:1692-1704. 10.2353/ajpath.2009.080739, 2671258, 19349367.
31. Ogunshola OO, Antic A, Donoghue MJ, Fan SY, Kim H, Stewart WB, Madri JA, Ment LR. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem 2002, 277:11410-11415. 10.1074/jbc.M111085200, 11777931.
32. Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007, 19:2003-2012. 10.1016/j.cellsig.2007.05.013, 17658244.
33. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K, Kamada T. "Ischemic tolerance" phenomenon found in the brain. Brain Res 1990, 528:21-24. 10.1016/0006-8993(90)90189-I, 2245337.
34. Miller BA, Perez RS, Shah AR, Gonzales ER, Park TS, Gidday JM. Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. NeuroReport 2001, 12:1663-1669. 10.1097/00001756-200106130-00030, 11409736.
35. Lee HT, Chang YC, Tu YF, Huang CC. VEGF-A/VEGFR-2 signaling leading to cAMP response element-binding protein phosphorylation is a shared pathway underlying the protective effect of preconditioning on neurons and endothelial cells. J Neurosci 2009, 29:4356-4368. 10.1523/JNEUROSCI.5497-08.2009, 19357264.
36. Canlon B, Fransson A. Reducing noise damage by using a mid-frequency sound conditioning stimulus. Neuroreport 1998, 9:269-274. 10.1097/00001756-199801260-00017, 9507967.
37. Lee JE, Nakagawa T, Kim TS, Iguchi F, Endo T, Dong Y, Yuki K, Naito Y, Lee SH, Ito J. A novel model for rapid induction of apoptosis in spiral ganglions of mice. Laryngoscope 2003, 113:994-999. 10.1097/00005537-200306000-00015, 12782811.
38. Nakagawa T, Kim TS, Murai N, Endo T, Iguchi F, Tateya I, Yamamoto N, Naito Y, Ito J. A novel technique for inducing local inner ear damage. Hear Res 2003, 176:122-127. 10.1016/S0378-5955(02)00768-2, 12583887.
39. Kada S, Nakagawa T, Ito J. A mouse model for degeneration of the spiral ligament. J Assoc Res Otolaryngol 2009, 10:161-172. 10.1007/s10162-008-0147-6, 19212789.